| ¿µ¹® | dopamine | ÇÑ±Û | µµÆÄ¹Î |
|---|---|---|---|
| ¼³¸í | È÷µå·Ï½ÃƼ¶ó¹ÎÀ¸·Î¼ »ý¸®È°¼º ¾Æ¹Î-Ä«Å×ÄݾƹÎÀÇ ÀÏÁ¾. ºÐÀÚ½ÄÀºC18H11NO2, ºÐÀÚ·®Àº 153.18ÀÌ´Ù. µ¿½Ä¹°¿¡ Á¸ÀçÇÏ´Â ¾Æ¹Ì³ë»êÀÇ Çϳª·Î, Àڿܼ± ÀÛ¿ëÀ¸·Î Ƽ·Î½Å¿¡¼ Çü¼ºµÇ°Å³ª L-DopaÀÇ Å»Åº»ê¿¡ ÀÇÇØ ü³»¿¡¼ »ý»êµÈ´Ù. ¸á¶ó´Ñ »ö¼Ò ÇÕ¼º °úÁ¤ÀÇ Áß°£ ¹°Áú·Î Äá°ú ½Ä¹°¿¡ ÀúÀåµÇ¾î ÀÖ´Ù. ³ú½Å°æ ¼¼Æ÷ÀÇ ÈïºÐ Àü´Þ¿¡ Áß¿äÇÑ ±¸½ÇÀ» ÇÑ´Ù. µµÆÄ¹Î¥â-»êÈÈ¿¼ÒÀÇ ÀÛ¿ë¿¡ ÀÇÇØ ³ë¸£¾Æµå·¹³¯¸°ÀÌ µÈ´Ù. ºÎ½Å¼öÁú-³ú-±³°¨½Å°æ°è-Æó-ÀÛÀºÃ¢ÀÚ-°£ µî¿¡µµ ¸¹ÀÌ Æ÷ÇԵǾî ÀÖ´Ù. ÆÄŲ½¼ ÁõÈıºÀÇ °æ¿ì ³ú ¾ÈÀÇ µµÆÄ¹Î ·®ÀÌ °¨¼ÒµÇ¸ç, ³úÁÙ±âÀÇ ÁÙ¹«´Ìü¿¡´Â ³ë¸£¾Æµå·¹³¯¸°º¸´Ù µµÆÄ¹ÎÀÌ ´Ù·® Æ÷ÇԵǾî ÀÖÀ½À» º¼ ¼ö ÀÖ´Ù´Â Á¡¿¡¼ µµÆÄ¹Î ÀÚü°¡ À̸¥¹Ù Ä«Å×ÄݾƹÎÀ» ÇÔÀ¯ÇÏ´Â ÀÛµ¿¼º ´º·±ÀÇ ½Å°æÀü´Þ¹°Áú·Î¼ ÀÛ¿ëÇϰí ÀÖÀ½ÀÌ ºÐ¸íÇØÁ³´Ù. |
||
| h.w.b. | hot water bag; ´õ¿î¹°ÁÖ¸Ó´Ï |
|---|---|
| BAG | buccoaxiogingival |
| BOW | bag of waters |
| BVM | bag-valve-mask; bronchovascular markings; Bureau of Veterinary Medicine |
| FATS | face and thigh squeeze [position for bag mask ventilation] |
| BVM | Bag Valve Mask |
|---|---|
| DA | 14C-dopamine |
| DA | 3)H]-dopamine |
| [(3)H]-DA | 3)H]-dopamine |
| dopamine | 3,4-Dihydroxyphenylethylamine |
striate body neurosis
| receptors, dopamine | Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behaviour of cells. (12 Dec 1998) |
|---|---|
| receptors, dopamine d1 | A class of dopamine receptors identified by their binding profiles for synthetic ligands, their molecular biology, and, perhaps, by their mode of action. (12 Dec 1998) |
| receptors, dopamine d2 | A class of dopamine receptors identified by their binding profiles for synthetic ligands, their molecular biology, and, perhaps, their mode of action. (12 Dec 1998) |
| dopamine | <drug> A catecholamine neurotransmitter and hormone (153 D), formed by decarboxylation of dehydroxyphenylalanine (dopa). A precursor of adrenaline and noradrenaline. Pharmacologic action: 1. Precursor of norepinephrine 2. Stimulates dopaminergic, alpha and beta-1 adrenergic receptors: 3. Dopaminergic (1-2 mcg/kg per min): cerebral, renal, and mesenteric vasodilation increase urine output 4. Mixed alpha and beta-1 (2-10 mcg/kg per min): increases cardiac ouput with moderate increase systemic vascular resistance 5. Predominantly alpha (>20 mcg/kg per min): increases systemic vascular resistance Uses: 1. Treat hypotension associated with bradycardia 2. Stimulate cardiac output and urine output Dose: 1. Start infusion at 1-5 mcg/kg per min and titrate to effect. 2. Use the lowest dose that provides the desired hemodynamic improvement. 3. Do not exceed 20 mcg/kg per min. Potential complications: 1. May increase pulmonary pressure and worsen pulmonary congestion. 2. May increase myocardial work without improving coronary blood flow, exacerbating myocardial ischemia 3. Stimulates heart rate and may cause supraventricular or ventricular arrhythmias (15 Mar 2000) |
| dopamine agents | Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons. (12 Dec 1998) |
| dopamine agonists | Drugs that bind to and activate dopamine receptors. (12 Dec 1998) |
| dopamine antagonists | Drugs that bind to but do not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (antipsychotic agents) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as antiemetics, in the treatment of tourette syndrome, and for hiccup. (12 Dec 1998) |
| dopamine beta-hydroxylase | <enzyme> Chemical name: 3,4-Dihydroxyphenethylamine, ascorbate:oxygen oxidoreductase (beta-hydroxylating) Registry number: EC 1.14.17.1 (12 Dec 1998) |
| dopamine beta-monooxygenase | A copper-containing enzyme catalyzing oxidation of ascorbate and 3,4-dihydroxyphenylethylamine simultaneously by O2 to yield norepinephrine, dehydroascorbate, and water; a crucial step in catecholamine metabolism. Synonym: dopamine beta-hydroxylase. (05 Mar 2000) |
| dopamine hydrochloride | A biogenic amine and neural transmitter substance, used as a vasopressor agent for treatment of shock. (05 Mar 2000) |
| dopamine uptake inhibitors | Drugs that block the transport of dopamine into axon terminals or into storage vesicles within terminals. most of the adrenergic uptake inhibitors also inhibit dopamine uptake. (12 Dec 1998) |
| Ambu bag | Proprietary name for a self-reinflating bag with nonrebreathing valves to provide positive pressure ventilation during resuscitation with oxygen or air. (05 Mar 2000) |
| bag | 1. To swell or hang down like a full bag; as, the skin bags from containing morbid matter. 2. To swell with arrogance. 3. To become pregnant. 1. A sack or pouch, used for holding anything; as, a bag of meal or of money. 2. A sac, or dependent gland, in animal bodies, containing some fluid or other substance; as, the bag of poison in the mouth of some serpents; the bag of a cow. 3. A sort of silken purse formerly tied about men's hair behind, by way of ornament. 4. The quantity of game bagged. 5. A certain quantity of a commodity, such as it is customary to carry to market in a sack; as, a bag of pepper or hops; a bag of coffee. Bag and baggage, all that belongs to one. To give one the bag, to disappoint him. Origin: OE. Bagge; cf. Icel. Baggi, and also OF. Bague, bundle, LL. Baga. Source: Websters Dictionary (01 Mar 1998) |
| bag cell neurons | <cell biology> Cluster of electrically coupled neurons in the abdominal ganglion of Aplysia that are homogeneous, easily dissected out and release peptides that stimulate egg laying. (18 Nov 1997) |
| bag-gel implant | An implant composed of a silicone rubber bag containing a silicone gel; used in augmentation mammaplasty. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
¹Ú½ºÅÍ¿°»êµµÆÄ¹Î160mg°ú5%Æ÷µµ´çÁÖ»ç¾×250ml - »õâ
|
Baxter AG |
E04270101 | Dopamine HCl | Àü¹®ÀǾàǰ | ±Þ¿© |
|
¹Ú½ºÅÍ¿°»êµµÆÄ¹Î160mg°ú5%Æ÷µµ´çÁÖ»ç¾×500ml - »õâ
|
Baxter AG |
E04270102 | Dopamine HCl | Àü¹®ÀǾàǰ | ±Þ¿© |
|
¹Ú½ºÅÍ¿°»êµµÆÄ¹Î320mg°ú5%Æ÷µµ´çÁÖ»ç¾× - »õâ
|
Baxter AG |
E04270111 | Dopamine HCl | Àü¹®ÀǾàǰ | ±Þ¿© |
|
¹Ú½ºÅÍ¿°»êµµÆÄ¹Î80mg°ú5%Æ÷µµ´çÁÖ»ç¾×250ml - »õâ
|
Baxter AG |
E04270091 | Dopamine HCl | Àü¹®ÀǾàǰ | ±Þ¿© |
|
¹Ú½ºÅÍ¿°»êµµÆÄ¹Î80mg°ú5%Æ÷µµ´çÁÖ»ç¾×500ml - »õâ
|
Baxter AG |
E04270092 | Dopamine HCl | Àü¹®ÀǾàǰ | ±Þ¿© |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|